Tormere Analytics
Overview
Stock Research
Portfolio Lab
Options Lab
Watchlist
Screener
Convergence
Data Explorer
Learn
Newsletter
Pricing
Developer
Loading portfolio…
Artal Group S.A. | Tormere
← Big Money
Artal Group S.A.
Est. AUM
$1.01B
13F long equity, this entity only
Positions
2
Period
Mar 2026 (Q1)
SEC EDGAR
View filings ↗
Current Holdings
What Changed
Pro
Mar 2026 (Q1)
All
2
Long Equity
2
#
Issuer
Class
Value
Shares
% Portfolio
Discretion
1
Cava Group Inc
COM
$769.2M
9507990
76.11%
DFND
2
Lexicon Pharmaceuticals Inc
COM NEW
$241.4M
154734327
23.89%
DFND
Values in USD (reported in $thousands on 13F). Source: SEC EDGAR.